162 related articles for article (PubMed ID: 15694209)
1. Hereditary leukodystrophies without identified mutations.
Robitaille Y
J Neurol Sci; 2005 Feb; 228(2):208-9. PubMed ID: 15694209
[No Abstract] [Full Text] [Related]
2. Progressive megalencephaly due to specific EIF2Bepsilon mutations in two unrelated families.
Passemard S; Gelot A; Fogli A; N'Guyen S; Barnerias C; Niel F; Doummar D; Arbues AS; Mignot C; de Villemeur TB; Ponsot G; Boespflug-Tanguy O; Rodriguez D
Neurology; 2007 Jul; 69(4):400-2. PubMed ID: 17646634
[No Abstract] [Full Text] [Related]
3. Central nervous system involvement in hereditary neuropathy with liability to pressure palsies: description of a large family with this association.
Sanahuja J; Franco E; Rojas-García R; Gallardo E; Combarros O; Begué R; Granés P; Illa I
Arch Neurol; 2005 Dec; 62(12):1911-4. PubMed ID: 16344349
[TBL] [Abstract][Full Text] [Related]
4. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter.
Geva M; Cabilly Y; Assaf Y; Mindroul N; Marom L; Raini G; Pinchasi D; Elroy-Stein O
Brain; 2010 Aug; 133(Pt 8):2448-61. PubMed ID: 20826436
[TBL] [Abstract][Full Text] [Related]
5. Molecular medicine: lost in translation.
Ainsworth C
Nature; 2005 Jun; 435(7042):556-8. PubMed ID: 15931189
[No Abstract] [Full Text] [Related]
6. Acute neurological deterioration in ovarioleukodystrophy related to EIF2B mutations: pregnancy with oocyte donation is a potentially precipitating factor.
Peter L; Niel F; Catenoix H; Jung J; Demarquay G; Petiot P; Rudigoz RC; Boespflug-Tanguy O; Ryvlin P; Mauguière F
Eur J Neurol; 2008 Jan; 15(1):94-7. PubMed ID: 18005052
[TBL] [Abstract][Full Text] [Related]
7. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
8. Adult-onset vanishing white matter leukoencephalopathy presenting as psychosis.
Denier C; Orgibet A; Roffi F; Jouvent E; Buhl C; Niel F; Boespflug-Tanguy O; Said G; Ducreux D
Neurology; 2007 May; 68(18):1538-9. PubMed ID: 17470759
[No Abstract] [Full Text] [Related]
9. TNFRSF1A R92Q mutation in association with a multiple sclerosis-like demyelinating syndrome.
Hoffmann LA; Lohse P; König FB; Feneberg W; Hohlfeld R; Kümpfel T
Neurology; 2008 Mar; 70(13 Pt 2):1155-6. PubMed ID: 18287568
[No Abstract] [Full Text] [Related]
10. X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease.
Isoardo G; Di Vito N; Nobile M; Benetton G; Fassio F
Neurology; 2005 Nov; 65(10):1672-3. PubMed ID: 16301507
[No Abstract] [Full Text] [Related]
11. Gap junction protein 12: "connexing" the pieces in the puzzle of myelination and leukodystrophy.
Mar S; Noetzel MJ
Neurology; 2008 Mar; 70(10):744-5. PubMed ID: 18316686
[No Abstract] [Full Text] [Related]
12. Interruption of SOX10 function in myelinopathies.
Lupski JR
Ann Neurol; 2010 Aug; 68(2):121-3. PubMed ID: 20695004
[No Abstract] [Full Text] [Related]
13. The ovarioleukodystrophy.
Mathis S; Scheper GC; Baumann N; Petit E; Gil R; van der Knaap MS; Neau JP
Clin Neurol Neurosurg; 2008 Dec; 110(10):1035-7. PubMed ID: 18678442
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clinical heterogeneity in eIF2B-related disorder.
Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
[TBL] [Abstract][Full Text] [Related]
15. Novel mutation in EIF2B gene in a case of adult-onset leukoencephalopathy with vanishing white matter.
Matsui M; Mizutani K; Ohtake H; Miki Y; Ishizu K; Fukuyama H; Shimohata T; Onodera O; Nishizawa M; Takayama Y; Shibasaki H
Eur Neurol; 2007; 57(1):57-8. PubMed ID: 17119336
[No Abstract] [Full Text] [Related]
16. The latest on leukodystrophies.
Schiffmann R; van der Knaap MS
Curr Opin Neurol; 2004 Apr; 17(2):187-92. PubMed ID: 15021247
[TBL] [Abstract][Full Text] [Related]
17. Natural history of adult-onset eIF2B-related disorders: a multi-centric survey of 16 cases.
Labauge P; Horzinski L; Ayrignac X; Blanc P; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Sèze J; Fogli A; Boespflug-Tanguy O
Brain; 2009 Aug; 132(Pt 8):2161-9. PubMed ID: 19625339
[TBL] [Abstract][Full Text] [Related]
18. Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
[TBL] [Abstract][Full Text] [Related]
19. Leukodystrophies with late disease onset: an update.
Köhler W
Curr Opin Neurol; 2010 Jun; 23(3):234-41. PubMed ID: 20216214
[TBL] [Abstract][Full Text] [Related]
20. Conversion of a normal MRI into an MRI showing a cystic leukoencephalopathy is not a known feature of vanishing white matter.
van der Knaap MS; Schiffmann R; Scheper GC
Neuropediatrics; 2007 Oct; 38(5):264. PubMed ID: 18330844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
